Back to News

Top Biopharma Brands Reach Audiences 10x More Qualified with ³Ô¹Ï±¬ÁÏ Crossix Prime Segments

³Ô¹Ï±¬ÁÏ Crossix helps 16 of the top 20 biopharmas more efficiently reach clinically relevant patients

PLEASANTON, CA ¡ª Apr. 23, 2024 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced that 16 of the top 20 biopharmas are increasing media efficiency with ³Ô¹Ï±¬ÁÏ Crossix Prime Segments, privacy-safe data helping life sciences brands reach highly-qualified health audiences. Since launching in April 2023, ³Ô¹Ï±¬ÁÏ Crossix Prime Segments have helped top biopharmas reach consumers that are 10 times more qualified than standard health audience segments through digital media campaigns.

¡°By using ³Ô¹Ï±¬ÁÏ Crossix Prime Segments we have been able to reach much more precise patient populations in our targeted campaigns," said Scott Carberry, product director for IMBRUVICA, Johnson & Johnson. ¡°Working with a trusted partner like ³Ô¹Ï±¬ÁÏ Crossix affords us a breadth of targeting capabilities, and we've seen success reaching both treatment-naive as well as specific treating for adherence audiences.¡±

³Ô¹Ï±¬ÁÏ Crossix¡¯s privacy-safe health audience segments can help marketers achieve multiple campaign goals across any channel. Marketing teams can leverage ³Ô¹Ï±¬ÁÏ Crossix Prime Segments to reach precise patient audiences and ³Ô¹Ï±¬ÁÏ Crossix Reach Segments for broad awareness and ROI at scale.

¡°A diverse set of health brands are using ³Ô¹Ï±¬ÁÏ Crossix Prime Segments to reach their most qualified audiences ¡ª from broad treatment categories to rare diseases,¡± said Jessica Daigle, head of ³Ô¹Ï±¬ÁÏ Crossix Audience Segments. ¡°³Ô¹Ï±¬ÁÏ Crossix is committed to delivering advanced solutions to help brands reach patients when it matters most.¡±

³Ô¹Ï±¬ÁÏ Crossix Prime Segments are custom-built to reach an advertiser¡¯s most qualified audience in a privacy-safe, HIPAA-compliant way. With data privacy embedded at its core, patented ³Ô¹Ï±¬ÁÏ Crossix SafeMine technology ensures that ³Ô¹Ï±¬ÁÏ Crossix Prime and Reach Segments protect patient privacy and are compliant with all applicable laws and regulations.

Learn more about using data and analytics to improve marketing effectiveness at ³Ô¹Ï±¬ÁÏ Commercial Summit in Boston, May 7-8. Life sciences industry professionals can register at veeva.com/CommercialSummit.

Additional Information
For more on ³Ô¹Ï±¬ÁÏ Crossix Prime Segments, visit: veeva.com/PrimeSegments
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world¡¯s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

³Ô¹Ï±¬ÁÏ Forward-looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2024, which you can find (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at .

###

Contact:
Alison Borris
³Ô¹Ï±¬ÁÏ Systems
925-226-8821
alison.borris@veeva.com